Scarica l'app Stockscreener
25.72
1.70%
0.43
Dopo l'orario di chiusura:
25.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Smith Nephew Plc Adr Borsa (SNN) Ultime notizie
Pressure Ulcer Device Market is Projected to Grow at a 5.6% CAGR, Reaching US$ 9,380.8 Million by 2034 | Fact.MR Report - GlobeNewswire Inc.
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Smith & Nephew Earnings: Quarterly Sales Suggest China Weakness Into 2025 - Morningstar
Smith & Nephew Sees Challenges in China Market - Morningstar
Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device
Analytical Overview: Smith & Nephew plc ADR (SNN)’s Ratios Tell a Financial Story - The Dwinnex
Smith+Nephew launches new Legion knee system - Mass Device
South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew Aligns Director Fees with Shares - TipRanks
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Smith+Nephew announces first Catalystem hip system procedures - Mass Device
Ratios in Focus: Analyzing Smith & Nephew plc ADR (SNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Smith+Nephew launches Total Ankle patient-matched guides - Mass Device
Upward Trajectory: Smith & Nephew plc ADR (SNN) Posts a Slidee, Closing at 30.67 - The Dwinnex
Saudi Arabia Antimicrobial Wound Care Dressings Market Size & Outlook, 2030 - Grand View Research
Medical Robotics Surgery Market to Grow at CAGR of 10.82% through 2033 - GlobeNewswire Inc.
InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device
Smith & Nephew plc ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
Kyphoplasty Market Research 2024 - GlobeNewswire Inc.
Smith+Nephew shares jump on strong H1 results and reaffirmed guidance - Investing.com
Global Alginate Dressing Market worth $1,129.4 million by - GlobeNewswire Inc.
Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device
Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha
Smith & Nephew shares surge as Cevian takes stake in medical devices group - Investing.com
Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device
Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance
Smith+Nephew rolls out new chronic wound treatment tech - Mass Device
7 Robotic Surgery Stocks to Buy for the Future of Healthcare - Yahoo Finance
Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device
Smith+Nephew kicks off Aetos shoulder system launch at AAOS - Mass Device
Smith+Nephew unveils expanded sports medicine portfolio - Mass Device
Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device
Smith+Nephew launches hip arthroplasty system in India - Mass Device
Smith+Nephew CFO to step down, revenue guidance increased - Mass Device
Smith+Nephew wins FDA clearance for shoulder replacement system - Mass Device
SNN: Add This Top Equipment Stock to Your Portfolio for a Strong Week Ahead - StockNews.com
Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device
Zimmer Biomet Holdings Inc. stock falls Thursday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market despite losses on the day - MarketWatch
8 Newly Undervalued 5-Star Stocks - Morningstar
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):